Cite
Depot-Medroxyprogesterone Acetate Does Not Reduce the Prophylactic Efficacy of Emtricitabine and Tenofovir Disoproxil Fumarate in Macaques.
MLA
Radzio, Jessica, et al. “Depot-Medroxyprogesterone Acetate Does Not Reduce the Prophylactic Efficacy of Emtricitabine and Tenofovir Disoproxil Fumarate in Macaques.” JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 67, no. 4, Dec. 2014, pp. 365–69. EBSCOhost, https://doi.org/10.1097/QAI.0000000000000340.
APA
Radzio, J., Hanley, K., Mitchell, J., Ellis, S., Deyounks, F., Jenkins, L., Heneine, W., & García-Lerma, J. G. (2014). Depot-Medroxyprogesterone Acetate Does Not Reduce the Prophylactic Efficacy of Emtricitabine and Tenofovir Disoproxil Fumarate in Macaques. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 67(4), 365–369. https://doi.org/10.1097/QAI.0000000000000340
Chicago
Radzio, Jessica, Krisztina Hanley, James Mitchell, Shanon Ellis, Frank Deyounks, Leecresia Jenkins, Walid Heneine, and J. Gerardo García-Lerma. 2014. “Depot-Medroxyprogesterone Acetate Does Not Reduce the Prophylactic Efficacy of Emtricitabine and Tenofovir Disoproxil Fumarate in Macaques.” JAIDS: Journal of Acquired Immune Deficiency Syndromes 67 (4): 365–69. doi:10.1097/QAI.0000000000000340.